Endothelial colony-forming cell therapy for heart morphological changes after neonatal high oxygen exposure in rats, a model of complications of prematurity

التفاصيل البيبلوغرافية
العنوان: Endothelial colony-forming cell therapy for heart morphological changes after neonatal high oxygen exposure in rats, a model of complications of prematurity
المؤلفون: Anik Cloutier, Arul Vadivel, Thuy An Mai-Vo, Camille Girard-Bock, Anne Monique Nuyt, Bernard Thébaud, Mariane Bertagnolli, Megan R. Sutherland, Shumei Zhong, Carla C. de Araújo, Rajesh S. Alphonse
المصدر: Physiological Reports
بيانات النشر: Wiley, 2018.
سنة النشر: 2018
مصطلحات موضوعية: Cardiovascular Conditions, Disorders and Treatments, Male, 0301 basic medicine, CD31, medicine.medical_specialty, Physiology, Angiogenesis, Cardiomyopathy, Maternal, Fetal and Neonatal Physiology, 030204 cardiovascular system & hematology, Cell therapy, Rats, Sprague-Dawley, 03 medical and health sciences, 0302 clinical medicine, Physiology (medical), Internal medicine, Jugular vein, medicine, Animals, Humans, Regeneration, Very Preterm Birth, Cellular and Molecular Conditions, Disorders and Treatments, Myocytes, Cardiac, Cells, Cultured, Original Research, Endothelial Progenitor Cells, Respiratory Conditions Disorder and Diseases, business.industry, preterm birth, Endothelial Cells, Heart, medicine.disease, Rats, 3. Good health, Oxygen, Platelet Endothelial Cell Adhesion Molecule-1, 030104 developmental biology, Animals, Newborn, Cord blood, Room air distribution, Cardiology, Cardiomyopathies, business, oxygen‐induced cardiomyopathy, Stem Cell Transplantation
الوصف: Very preterm birth is associated with increased cardiovascular diseases and changes in myocardial structure. The current study aimed to investigate the impact of endothelial colony‐forming cell (ECFC) treatment on heart morphological changes in the experimental model of neonatal high oxygen (O2)‐induced cardiomyopathy, mimicking prematurity‐related conditions. Sprague–Dawley rat pups exposed to 95% O2 or room air (RA) from day 4 (P4) to day 14 (P14) were randomized to receive (jugular vein) exogenous human cord blood ECFC or vehicle at P14 (n = 5 RA‐vehicle, n = 8 RA‐ECFC, n = 8 O2‐vehicle and n = 7 O2‐ECFC) and the hearts collected at P28. Body and heart weights and heart to body weight ratio did not differ between groups. ECFC treatment prevented the increase in cardiomyocyte surface area in both the left (LV) and right (RV) ventricles of the O2 group (O2‐ECFC vs. O2‐vehicle LV: 121 ± 13 vs. 179 ± 21 μm2, RV: 118 ± 12 vs. 169 ± 21 μm2). In O2 rats, ECFC treatment was also associated with a significant reduction in interstitial fibrosis in both ventricles (O2‐ECFC vs. O2‐vehicle LV: 1.07 ± 0.47 vs. 1.68 ± 0.41% of surface area, RV: 1.01 ± 0.74 vs. 1.77 ± 0.67%) and in perivascular fibrosis in the LV (2.29 ± 0.47 vs. 3.85 ± 1.23%) but in not the RV (1.95 ± 0.95 vs. 2.74 ± 1.14), and with increased expression of angiogenesis marker CD31. ECFC treatment had no effect on cardiomyocyte surface area or on tissue fibrosis of RA rats. Human cord blood ECFC treatment prevented cardiomyocyte hypertrophy and myocardial and perivascular fibrosis observed after neonatal high O2 exposure. ECFC could constitute a new regenerative therapy against cardiac sequelae caused by deleterious conditions of prematurity.
تدمد: 2051-817X
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25e1c420a4c3d5be143173bf8a618429Test
https://doi.org/10.14814/phy2.13922Test
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....25e1c420a4c3d5be143173bf8a618429
قاعدة البيانات: OpenAIRE